About us

The Team

Aurélien Rizk

CEO

PhD in Computer Science
10 years experience in systems biology.

AR

Luca Zenone

CFO & COO

MSc in Business
Administration running all the finance, legal and operations of the company.

LZ

Jens Kurth

HEAD OF DEVELOPMENT

PhD in Biochemistry
25 years experience driving the development, regulatory approval and commercialization of new drugs.

JK

Mirjam Zimmermann

HEAD OF RESEARCH

PhD in Biochemistry
6 years cellular biology, cell signaling and pharmacology.

MZ

Yaroslav Nikolaev

HEAD OF COMPUTATIONAL SCIENCE

PhD with dual Biology-MSc Computation-MSc background
12 years research experience in structural and systems biology.

YN

Susanne Roth

PRINCIPAL SCIENCIST SYSTEMS BIOLOGY

PhD in Systems Biology
6 years GPCR signaling and mathematical modeling.

SR

Georgi Kanev

SCIENTIST MACHINE LEARNING

PhD in Computational Medicinal Chemistry

GK

Tomek Stepniewski

SCIENTIST COMPUTATIONAL CHEMISTRY

PhD in Biomedicine

TS

Agne Tilunaite

SCIENTIST SYSTEM BIOLOGY

PhD in Mathematical Medicine and Biology

AT

Alessandro Potenza

SCIENTIST BIOLOGY

MSc Molecular Biology

AP

Nadine Dobberstein

LABORATORY TECHNICIAN

MSc Quantitative and Systems Biology

ND

Mierelle Schuijt

LABORATORY TECHNICIAN

MSc Biomolecular Sciences

MS

Kylie Pan

PhD STUDENT

MSc Experimental Pharmacology and Therapeutics

KP

Board of Directors

Prof. Dr. Jens Gobrecht

Prof. Dr. Jens Gobrecht

HEAD OF BOARD OF DIRECTORS

Prof. emeritus Laboratory for Micro- and Nanotechnology at the Paul Scherrer Institute (PSI); Co-founder of EULITHA AG; Honorary Member of the Swiss Nanoscience Institute

Dr. Aurélien Rizk

Dr. Aurélien Rizk

BOARD MEMBER

PhD Computer Science; Co-Founder and CEO InterAx Biotech; Co-Founder Algorizk
Luca Zenone

Luca Zenone

Luca Zenone

BOARD MEMBER

MSc ETH Management, Technology and Economics; Engineering and Management Consulting; Co-Founder, CFO and COO InterAx Biotech

Dr. Yiannis Monovoukas

Dr. Yiannis Monovoukas

BOARD MEMBER

Managing Partner, Falcon III and SpringTide Ventures Fund I; CEO, Helios Cardiovascular and AuraGen Aesthetics

Dr. Bettina Ernst

Dr. Bettina Ernst

BOARD MEMBER

CEO of PRECLIN Biosystems; Board member of multiple biotech companies; VP of Board of Swiss Biotech Association

Scientific Advisors

Prof. Gebhard Schertler

Prof. Gebhard Schertler

Prof. Gebhard Schertler

HEAD OF SCIENTIFIC ADVISORY BOARD

Professor for Structural Biology ETH Zürich; Head of Biology and Chemistry at the Paul Scherrer Institute (PSI)
Dr. Chris de Graaf

Dr. Chris de Graaf

Dr. Chris de Graaf

SCIENTIFIC ADVISOR

Director of Computational Chemistry, Heptares Therapeutics
Prof. Michel Bouvie

Prof. Michel Bouvier

Prof. Michel Bouvier

SCIENTIFIC ADVISOR

Professor for Biochemistry Université de Montréal; CEO Institute for Research in Immunology and Cancer (IRICoR), Montreal

Dr. Jana Selent

Dr. Jana Selent

SCIENTIFIC ADVISOR

Associate Professor & Miguel Servet Researcher Research Group on Biomedical Informatics (GRIB) 
Hospital del Mar Medical Research Institute (IMIM)
DCEXS, Pompeu Fabra University (UPF)

Prof. Ruedi Aebersold

Prof. Ruedi Aebersold

SCIENTIFIC ADVISOR

Pioneer in the field of proteomics and systems biology

Dr. Philipp Berger

Dr. Philipp Berger

SCIENTIFIC ADVISOR

Senior Scientist, Paul Scherrer Institute (PSI)

With Support From

Our Story

2010
2010
During his PhD at the Paul Scherrer Institute, Martin Ostermaier plants the "Arrestin" seed of InterAx
2011
During his PostDoc at the Paul Scherrer Institute, Aurßelien Rizk plants the "Systems Biology" seed of InterAx
2014
2014
After his MSc in Management Technology and Economics, Lucas Zenone plants the "Business" seed of InterAx
August 2014
The project receives 150k CHF from the ETH Foundation